164 results
UPLOAD
ENTA
Enanta Pharmaceuticals Inc
27 Nov 23
Letter from SEC
12:00am
and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence
S-3
EX-4.3
ENTA
Enanta Pharmaceuticals Inc
22 Nov 23
Shelf registration
4:38pm
appropriate, the premium, if any, on, and any Additional Amounts in respect of, the Security.
“Responsible Officer” means any officer of the Trustee … is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency;
(n) the designation of the currency
S-3
d6fcxd4 vfi
22 Nov 23
Shelf registration
4:38pm
8-K
EX-10.1
o2bs grbc
27 Apr 23
Non-Dilutive and Strengthens Balance Sheet
4:43pm
424B5
pq64od gnx797r
26 Aug 22
Prospectus supplement for primary offering
4:06pm